Contact Investigation of Melioidosis Cases Reveals Regional Endemicity in Puerto Rico | Zendy

Thomas Doker | Zendy; Tyler M. Sharp | Zendy; Brenda Rivera-García | Zendy; Janice PérezPadilla | Zendy; Tina J. Benoit | Zendy; Esther M. Ellis | Zendy; Mindy G. Elrod | Zendy; Jay E. Gee | Zendy; WunJu Shieh | Zendy; Cari A. Beesley | Zendy; Kyle R. Ryff | Zendy; Rita M. Traxler | Zendy; Renee L. Galloway | Zendy; Dana L. Haberling | Zendy; Lance A. Waller | Zendy; Sean V. Shadomy | Zendy; William A. Bower | Zendy; Alex R. Hoffmaster | Zendy; Henry Walke | Zendy; David D. Blaney | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Contact Investigation of Melioidosis Cases Reveals Regional Endemicity in Puerto Rico

Author(s) -

Thomas Doker,

Tyler M. Sharp,

Brenda Rivera-García,

Janice PérezPadilla,

Tina J. Benoit,

Esther M. Ellis,

Mindy G. Elrod,

Jay E. Gee,

WunJu Shieh,

Cari A. Beesley,

Kyle R. Ryff,

Rita M. Traxler,

Renee L. Galloway,

Dana L. Haberling,

Lance A. Waller,

Sean V. Shadomy,

William A. Bower,

Alex R. Hoffmaster,

Henry Walke,

David D. Blaney

Publication year - 2014

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1093/cid/ciu764

Subject(s) - melioidosis , burkholderia pseudomallei , medicine , antimicrobial , microbiology and biotechnology , burkholderia , environmental health , immunology , bacteria , pathology , biology , genetics

Melioidosis results from infection with Burkholderia pseudomallei and is associated with case-fatality rates up to 40%. Early diagnosis and treatment with appropriate antimicrobials can improve survival rates. Fatal and nonfatal melioidosis cases were identified in Puerto Rico in 2010 and 2012, respectively, which prompted contact investigations to identify risk factors for infection and evaluate endemicity.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research